 |
 |
|
||
Groupe de recherche thérapeutique sur la maladie de Crohn et
la rectocolite hémorragique |
||||
|
2007.Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.
Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M,
Bourreille A, Duclos B, Seksik P, Mary JY, Colombel JF.
(Gut. 2007 May 15)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
D'Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, Lémann M, Marteau P, Rutgeerts P,
Schölmerich J, Sutherland LR. (Gastroenterology. 2007 Feb;132(2):763-86. Epub 2006 Dec 20.) Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.
Daniel F, Loriot MA, Seksik P, Cosnes J, Gornet JM, Lémann M, Fein F, Vernier-Massouille G, De Vos M, Boureille A,
Treton X, Flourié B, Roblin X, Louis E, Zerbib F, Beaune P, Marteau P.
(IBD 2007 Jan;13(1):19-23.)
2006.A simple biological score for predicting low risk of short-term relapse in Crohn's disease
Consigny Y, Modigliani R, Colombel JF, Dupas JL, Lémann M, Mary JY; Groupe d'Etudes Thérapeutiques des Affections
Inflammatoires Digestives (GETAID). (IBD 2006 Jul;12(7):551-7.) Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease - A randomized, double-blind, placebo-controlled GETAID trial
Marteau P, Lémann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y, Cadiot G,
Soulé JC, Bourreille A, Metman E, EH, Lerebours E, Carbonnel F, Dupas JL,
Veyrac M, Coffin B, Moreau J, Mary JY and the GETAID (Gut 2006 Jun;55(6):842-7. Epub 2005 Dec 23)
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial
Lemann M, Mary JY, Duclos B, Veyrac M, Dupas JL, Delchier JC, Laharie D, Moreau J, Cadiot G, Picon L, Bourreille A,
Sobahni I, Colombel JF and the GETAID. (Gastroenterology. 2006 Apr;130(4):1054-61.)
2005.Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo
Palascak-Juif V, Bouvier AM, Cosnes J, Flourié B, Bouché O, Cadiot G, Lémann M, Bonaz B, Denet C, Marteau P,
Gambiez L, Beaugerie L, Faivre J, Carbonnel F. (IBD 2005 Sep;11(9):828-32.)
A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn's Disease Patients in Long-term Remission on Azathioprine
Lemann M, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Modigliani R,
Bouhnik Y. and GETAID. (Gastroenterology. 2005 Jun;128(7):1812-8.)
ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.
Allorge D, Hamdan R, Broly F, Libersa C, Colombel JF. (Gut. 2005 Apr;54(4):565.)
2003.Clustering of Crohn's disease within affected sibships. Eur J Hum Genet.
Hugot JP, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M,
Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Zouali H, Lesage S,
Chamaillard M, Macry J, Thomas G, Victor JM; GETAID. (2003 Feb;11(2):179-84.PMID: 12634866 [PubMed - indexed for MEDLINE].)
Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
Bonaz B, Boitard J, Marteau P, Lemann M, Coffin B, Flourie B, Belaiche, J Cadiot G,
Metman EH, Cortot A, Colombel JF; Getaid. (Aliment Pharmacol Ther. 2003 Aug 15;18(4):401-8.)
2002.Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride Aliment Pharmacol Ther
Abitbol V, Mary JY, Roux C, Soule JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E,
Chaussade S; Groupe D'etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID).
(2002 May;16(5):919-27 PMID: 11966500 [PubMed - indexed for MEDLINE])
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet
Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M,
Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M,
Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group.; EPIMAD Group.; GETAID. (2002 Apr;70(4):845-57.)
2001.CARD4/NOD1 is not involved in inflammatory bowel disease.
Zouali H, Lesage S, Merlin F, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C,
Gassull M, Christensen S, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Chamaillard M,
Thomas G, Hugot JP; EPWG group.; EPIMAD group. (Gut 2003 Jan;52(1):71-4.)
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. Eur J Hum Genet
Zouali H, Chamaillard M, Lesage S, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C,
Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Macry J,
Selinger-Leneman H, Thomas G, Hugot JP; GETAID. (2001 Oct;9(10):731-42.)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.Nature.
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C,
O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R,Laurent-Puig P,
Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. (2001 May 31;411(6837):599-603.)
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol.
Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, Colombel JF;
Groupe d'Etudes Therapeutique des Affections Inflammatoires Digestives (GETAID).
(2001 Oct;96(10):2915-20.)
2000.Genetic analyses of chromosome 12 loci in Crohn's disease.
Lesage S, Zouali H, Colombel JF, Belaiche J, Cezard JP, Tysk C, Almer S, Gassull M, Binder V,
Chamaillard M, Le Gall I, Thomas G, Hugot JP. (Gut. 2000 Dec;47(6):787-91.)
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.
Colombel JF, Ferrari N, Debuysere H, Marteau P, Gendre JP, Bonaz B, Soule JC, Modigliani R,
Touze Y, Catala P, Libersa C, Broly F. (Gastroenterology 2000 Jun;118(6):1025-30.)
1999.A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives ( GETAID ).
Colombel JF, Lemann M, Cassagnou M, Bouhnik Y, Duclos B, Dupas JL, Notteghem B, Mary JY.
(Am J Gastroenterol 1999 Mar;94(3):674-8.)
1996.Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.
Modigliani R, Colombel JF, Dupas JL, Dapoigny M, Costil V, Veyrac M, Duclos B, Soule JC,
Gendre JP, Galmiche JP, Danne O, Cadiot G, Lamouliatte H, Belaiche J, Mary JY.
(Gastroenterology 1996 Mar;110(3):688-93.)
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature.
Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL,
Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE,
Cortot A, Colombel JF, Thomas G. (1996 Feb 29;379(6568):821-3.)
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID).
Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, Sarfaty E, Valleur P, Dupas JL,
Daurat M, Faucheron JL, Lerebours E, Michot F, Belaiche J, Jacquet N, Soule JC, Rothman N,
Gendre JP, Malafosse M. (Eur J Gastroenterol Hepatol 1996 Mar;8(3):229-33.)
Clinical characteristics of Crohn's disease in 72 families. Gastroenterology.
Colombel JF, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, Gendre JP,
Modigliani R, Belaiche J, Hostein J, Hugot JP, van Kruiningen H, Cortot A.
(1996 Sep;111(3):604-7.)
1995.Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.
Sahmoud T, Hoctin-Boes G, Modigliani R, Bitoun A, Colombel JF, Soule JC, Florent C,
Gendre JP, Lerebours E, Sylvester R. (Gut 1995 Dec;37(6):811-8.)
1994.Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.
Lerebours E, Bussel A, Modigliani R, Bastit D, Florent C, Rabian C, Rene E, Soule JC.
(Gastroenterology. 1994 Aug;107(2):357-61.)
Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.
Cellier C, Sahmoud T, Froguel E, Adenis A, Belaiche J, Bretagne JF, Florent C, Bouvry M,
Mary JY, Modigliani R. (Gut. 1994 Feb;35(2):231-5.)
1993.Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID).
Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soule JC,Galmiche JP, Lerebours E,
Descos L, Viteau JM, et al. (Gastroenterology. 1993 Feb;104(2):435-9.)
1990.Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives.
Modigliani R, Mary JY, Simon JF, Cortot A, Soule JC, Gendre JP, Rene E.
(Gastroenterology. 1990 Apr;98(4):811-8.)
1989.Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).
Mary JY, Modigliani R. (Gut. 1989 Jul;30(7):983-9.)
1983.Effect of levamisole on the prevention of developmental flare-ups in quiescent Crohn's disease: a prospective multicenter controlled trial in 155 patients Gastroenterol Clin Biol.
Modigliani R, Pieddeloup C, Hecketsweiler P, Descos L, Lerebours E, Vernisse B, Costil V,
Bitoun A, Lacroute JM, Maire P, et al. (1983 Aug-Sep;7(8-9):683-92.)
|
|
| © GETAID |  |